EVALUATION OF AN AUTOMATED COAGULATION ANALYZER
The ACL (IL-Automated Coagulation Laboratory from the Fisher Scientific Group) is the first microcentrifugal analyzer incorporating 2 reading channels, a coagulometric channel consisting of a laser light source and a chromogenic channel consisting of a halogen light source. We have evaluated the instrument for precision and accuracy using different reagents for both clotting and the chromogenic assays. Replicate samples were run in both the PT and APTT modes using 4 different reagents. The reagent with the least particles had the greatest precision. The mean values for APTTs and PTs using a particle free reagent were 68.7 ± .83“ for the APTT (C.V. 1.2%), and 30.2 ± .33” (C.V. 1.1%) for the PT. A fibrinogen assay measured on the ACL (delta light scatter of the prothrombin time) was compared to the Clause fibrinogen assay in three population groups: the adult, the newborn and patients receiving thrombolytic therapy. The correlation for the adult and newborn was good with r values of .911 (n = 51) and .96 (n = 36) respectively. The thrombolytic therapy group had poor correlation r = .32. Antithrombin III (ATIII) and a2 antiplasmin (AP) assays were measured on the ACL using IIs chromogenic method. These were compared to an ATIII chromogenic method (Kahle) using a Gilford SBA 300 analyzer and α2 AP assay using a Protopath (Dade). The correlations were ATIII, r=.95 and α2 AP, r=.82. The plasminogen method of Friberger was adapted to the ACL giving us comparable results to those read off the Gilford SBA 300 (r=.93). With the introduction of the ACL we have been able to: 1) reduce the technical time required for assays by one half; 2) reduce reagent costs by one half to three-quarters; 3) reduce the amount of plasma required for screening tests by half the volume, which has greatly facilitated neonatal coagulation testing